Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy.
Salpini R, D'Anna S, Alkhatib M, Piermatteo L, Tavelli A, Benedetti L, Quiros Roldan E, Cingolani A, Papalini C, Carrara S, Malagnino V, Puoti M, Sarmati L, Ceccherini-Silberstein F, Perno CF, Monforte AD, Svicher V. Salpini R, et al. Among authors: piermatteo l. Int J Infect Dis. 2025 Jan;150:107294. doi: 10.1016/j.ijid.2024.107294. Epub 2024 Nov 5. Int J Infect Dis. 2025. PMID: 39505254 Free article.
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, Gennari W, Forbici F, Berno G, Piermatteo L, Borghi V, Pinnetti C, Vergori A, Mondi A, Parruti G, Di Sora F, Iannetta M, Lichtner M, Latini A, Mussini C, Sarmati L, Perno CF, Girardi E, Antinori A, Ceccherini-Silberstein F, Maggi F, Santoro MM; Italian HIV Drug Resistance Group. Fabeni L, et al. Among authors: piermatteo l. J Antimicrob Chemother. 2024 Sep 3;79(9):2152-2162. doi: 10.1093/jac/dkae189. J Antimicrob Chemother. 2024. PMID: 39028674 Free PMC article.
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses.
Sun B, da Costa KAS, Alrubayyi A, Kokici J, Fisher-Pearson N, Hussain N, D'Anna S, Piermatteo L, Salpini R, Svicher V, Kucykowicz S, Ghosh I, Burns F, Kinloch S, Simoes P, Bhagani S, Kennedy PTF, Maini MK, Bashford-Rogers R, Gill US, Peppa D. Sun B, et al. Among authors: piermatteo l. Hepatology. 2024 Sep 1;80(3):649-663. doi: 10.1097/HEP.0000000000000877. Epub 2024 Apr 30. Hepatology. 2024. PMID: 38687604
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Ferrari L, Ruggiero A, Stefani C, Benedetti L, Piermatteo L, Andreassi E, Caldara F, Zace D, Pagliari M, Ceccherini-Silberstein F, Jones C, Iannetta M, Geretti AM; EVAN-COV Study Group. Ferrari L, et al. Among authors: piermatteo l. Sci Rep. 2024 Apr 9;14(1):8337. doi: 10.1038/s41598-024-58597-4. Sci Rep. 2024. PMID: 38594459 Free PMC article.
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Salpini R, Piermatteo L, D'Anna S, Carrara S, Malagnino V, Mazzotta V, Brancaccio G, Marchetti GC, Rosselli Del Turco E, Rossotti R, Mussini C, Antinori A, Lo Caputo S, Ceccherini Silberstein F, Gaeta GB, Svicher V, Puoti M; Icona Foundation Study Group. d'Arminio Monforte A, et al. Among authors: piermatteo l. Liver Int. 2024 Feb;44(2):603-613. doi: 10.1111/liv.15804. Epub 2023 Dec 15. Liver Int. 2024. PMID: 38100128 Free article.
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication.
Salpini R, Piermatteo L, Torre G, D'Anna S, Khan S, Duca L, Bertoli A, La Frazia S, Malagnino V, Teti E, Iannetta M, Paba P, Ciotti M, Lenci I, Francioso S, Paquazzi C, Lichtner M, Mastroianni C, Santopaolo F, De Sanctis G, Pellicelli A, Galati G, Moretti A, Casinelli K, Caterini L, Iapadre N, Parruti G, Vecchiet I, Paoloni M, Marignani M, Ceccherini-Silberstein F, Baiocchi L, Grelli S, Sarmati L, Svicher V. Salpini R, et al. Among authors: piermatteo l. Int J Infect Dis. 2024 Jan;138:1-9. doi: 10.1016/j.ijid.2023.11.005. Epub 2023 Nov 7. Int J Infect Dis. 2024. PMID: 37944585 Free article.
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing.
Bellocchi MC, Scutari R, Carioti L, Iannetta M, Marchegiani G, Piermatteo L, Coppola L, Tedde S, Duca L, Malagnino V, Ansaldo L, Braccialarghe N, D Anna S, Santoro MM, Di Lorenzo A, Salpini R, Teti E, Svicher V, Andreoni M, Sarmati L, Ceccherini-Silberstein F, On Behalf Of The Ptv-Utv-Id-Covid Group. Bellocchi MC, et al. Among authors: piermatteo l. Viruses. 2023 Aug 9;15(8):1711. doi: 10.3390/v15081711. Viruses. 2023. PMID: 37632054 Free PMC article.
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
Piermatteo L, D'Anna S, Bertoli A, Bellocchi M, Carioti L, Fabeni L, Alkhatib M, Frazia S, Lichtner M, Mastroianni C, Sanctis G, Marignani M, Pasquazzi C, Iapadre N, Parruti G, Cappiello G, Vecchiet J, Malagnino V, Grelli S, Ceccherini-Silbertein F, Andreoni M, Sarmati L, Svicher V, Salpini R. Piermatteo L, et al. Emerg Microbes Infect. 2023 Dec;12(1):2219347. doi: 10.1080/22221751.2023.2219347. Emerg Microbes Infect. 2023. PMID: 37288750 Free PMC article.
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimen.
Scutari R, Galli L, Alteri C, Poli A, Piermatteo L, Bigoloni A, Perno CF, Lazzarin A, Ceccherini-Silberstein F, Castagna A, Santoro MM, Gianotti N. Scutari R, et al. Among authors: piermatteo l. Int J Antimicrob Agents. 2023 May;61(5):106771. doi: 10.1016/j.ijantimicag.2023.106771. Epub 2023 Mar 3. Int J Antimicrob Agents. 2023. PMID: 36870403 Clinical Trial.
34 results